Illumina Inc

Closed

SectorHealthcare

175.73 -2.84

Overview

Share price change

24h

Current

Min

174.14

Max

180.28

Key metrics

By Trading Economics

Income

-200M

134M

Sales

-68M

1.1B

P/E

Sector Avg

29.342

50.958

EPS

1.15

Profit margin

12.282

Employees

8,600

EBITDA

-219M

226M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-15.26% downside

Dividends

By Acuity

Next Earnings

30 lip 2026

Market Stats

By TradingEconomics

Market Cap

4.9B

24B

Previous open

178.57

Previous close

175.73

News Sentiment

By Acuity

20%

80%

26 / 342 Ranking in Healthcare

Illumina Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 cze 2026, 23:16 UTC

Illumina Inc shares are lower in after-market trading, with no specific news identified to explain the movement. Broader U.S. equities show mixed performance.

26 cze 2026, 23:16 UTC

Illumina Inc shares are trading lower in after-market hours. Broader market concerns over rising interest rates and inflation may be influencing investor behavior.

25 cze 2026, 23:26 UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

24 cze 2026, 20:02 UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23 cze 2026, 22:46 UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22 cze 2026, 19:32 UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19 cze 2026, 00:02 UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18 cze 2026, 23:01 UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17 cze 2026, 20:03 UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16 cze 2026, 19:56 UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15 cze 2026, 13:02 UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12 cze 2026, 19:56 UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11 cze 2026, 20:03 UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10 cze 2026, 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9 cze 2026, 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8 cze 2026, 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5 cze 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4 cze 2026, 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3 cze 2026, 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2 cze 2026, 23:21 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1 cze 2026, 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29 maj 2026, 20:03 UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28 maj 2026, 23:26 UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27 maj 2026, 20:02 UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21 maj 2026, 19:42 UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20 maj 2026, 19:56 UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

19 maj 2026, 20:03 UTC

Illumina Inc's shares are higher, supported by gains in the Life Sciences Tools & Services sub-sector, despite midday fluctuations.

18 maj 2026, 19:15 UTC

Correlated Moves

Illumina Inc shares are lower, continuing a four-session decline amid rising Treasury yields and broader market trends, including a drop in the Russell 2000 Index.

15 maj 2026, 23:56 UTC

Illumina Inc shares are lower in after-market hours, following a decline during the session amid broader market volatility and rising initial jobless claims.

Peer Comparison

Price change

Illumina Inc Forecast

Price Target

By TipRanks

-15.26% downside

12 Months Forecast

Average 153.46 USD  -15.26%

High 200 USD

Low 95 USD

Based on 13 Wall Street analysts offering 12 month price targets forIllumina Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

7

Buy

3

Hold

3

Sell

Sentiment

By Acuity

26 / 342 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat